Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119845) titled 'Efficacy and safety of tegilerdine for postoperative analgesia in obese patients undergoing bariatric surgery' on March 4.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuyang Hospital Affiliated to Anhui Medical University
Condition:
Bariatric surgery
Intervention:
Sufentanil Group:Sufentanil used for induction and maintenance of anesthesia
sufentanil 0.1 ug/kg administered 20 minutes before surgery end
PCA pump connected (100 ug sufentanil + 8 mg ondansetron diluted to 100 ml with normal saline)
background infusion rate of 2 ml/h, bolus dose of 1 ml per request, lockout inter...